Skip to main content
  • Cath Lab Recap: Low-Risk TAVR; MitraClip Approval; Thyroid and Ablation Risk

    Interventional cardiology news to note

    The FDA approved the third-generation version of MitraClip. Upgrades make the mitral valve repair device easier to use in difficult anatomies, according to the announcement from Abbott.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details